Desjardins Global Asset Management’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
$1.81M Sell
6,679
-80
-1% -$19.8K 0.19% 126
2023
Q3
$1.66M Sell
6,759
-577
-8% -$158K 0.18% 131
2023
Q2
$2.23M Buy
7,336
+5,770
+368% +$1.6M 0.26% 85
2023
Q1
$413K Buy
1,566
+866
+124% +$220K 0.05% 287
2022
Q4
$167K Buy
700
+5
+0.7% +$1.12K 0.03% 359
2022
Q3
$127K Hold
695
0.02% 375
2022
Q2
$116K Sell
695
-87
-11% -$18.7K 0.02% 372
2022
Q1
$195K Sell
782
-48
-6% -$12.1K 0.02% 357
2021
Q4
$213K Buy
+830
New +$203K 0.02% 358

Other funds holding HCA

Desjardins Global Asset Management's HCA Position: Q4 2023 in Review

Desjardins Global Asset Management reduced its HCA Healthcare (HCA) stake by 1.2% in Q4 2023, selling an estimated $19.8K and leaving 6,679 shares worth $1.81M. The position accounts for 0.19% of the portfolio, ranked #126.

Desjardins Global Asset Management first reported a position in HCA in Q4 2021 and has held it in 9 quarters since. The position peaked at $2.23M in Q2 2023. 1,056 funds tracked by Wall St. Rank hold HCA as of Q4 2023.

  • Desjardins Global Asset Management held 6,679 shares of HCA Healthcare worth $1.81M as of Q4 2023.
  • Desjardins Global Asset Management sold 80 HCA Healthcare shares in Q4 2023, an estimated $19.8K.
  • HCA Healthcare made up 0.19% of Desjardins Global Asset Management's portfolio in Q4 2023, its #126 holding.
  • Desjardins Global Asset Management first reported a position in HCA Healthcare in Q4 2021 and has held it in 9 quarters since.
  • Desjardins Global Asset Management's HCA Healthcare position peaked at $2.23M in Q2 2023.
  • 1,056 funds tracked by Wall St. Rank held HCA Healthcare as of Q4 2023.

Based on Desjardins Global Asset Management's 13F filing for Q4 2023, filed 30 Jan 2024.